Abstract
Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have